echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Microclassroom Issue 8 Prof. Jiang Hua: Definition, Mechanism, Diagnosis and Treatment of MGRS

    Microclassroom Issue 8 Prof. Jiang Hua: Definition, Mechanism, Diagnosis and Treatment of MGRS

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    There are many types of monoclonal immunoglobulin-related diseases, often involving the kidneys, heart and other organs




    The mechanism of renal damage in MGRS is very complex.



    Figure 1 Mechanism of MGRS kidney damage


    Most MGRS require pathological diagnosis and identification of renal biopsy



    In 2019, the MGRS Consensus Report 2 published by the International Kidney and Monoclonal Gammopathy Study Group (IKMG) proposed a recommended diagnostic process: for patients suspected of MGRS or diagnosed with MGUS, renal function tests are required before treatment.



    After a clear diagnosis, targeted treatment should be carried out for patients with MGRS, and the treatment should follow the following principles: the main purpose of MGRS treatment is to protect renal function, and a balance between treatment toxicity and potential benefits should be achieved during treatment; for advanced chronic kidney disease ( CKD), the purpose of clonal targeted therapy should be shifted to reducing the risk of MGRS recurrence after kidney transplantation; for advanced CKD patients who are not suitable for transplantation, the pros and cons of the treatment should be balanced, and only when there is extrarenal involvement or malignant tumors.



    At present, except for AL amyloidosis, there are no relevant guidelines for the treatment of other types of MGRS



    In recent years , the CD38 monoclonal antibody-daratumumab has also published many important research data in the field of amyloidosis .


    Figure 2 Results of organ remission in each subgroup of the ANDROMEDA study

    Summarize 

    MGRS, monoclonal immunoglobulinopathies of renal significance, are a group of clonal disorders of B cells or plasma cells that cause renal damage through the production of monoclonal immunoglobulins


    MGRS differentiates different types according to monoclonal immunoglobulin types and their deposition sites


    The diagnosis of MGRS needs to be evaluated from the two aspects of hematology and renal involvement


    Renal biopsy should be performed in all patients with suspected MGRS


    The main purpose of MGRS treatment is to protect renal function, and the treatment plan should be considered from two aspects of renal disease treatment and anti-B cell cloning therapy.

    END
    references

    [1] Nelson Leung, et al.
    N Engl J Med.
    2021 May 20;384(20):1931-41.

    [2] Leung N, et al.
    Nat Rev Nephrol.
    2019 Jan;15(1):45-59.

    [3] Fermand JP, et al.
    Blood.
    2013 Nov 21;122(22):3583-90.

    [4] Efstathios Kastritis, et al.
    2021ASCO.

    [5]Raymond Comenzo, et al.
    2021ASH.
    Abstract Oral 159.

    MED-DAR-CN-0774 Content Approved Date: 8/11/2022

    For reference only by medical and pharmaceutical professionals, reproduction and dissemination are strictly prohibited

    Edit: Arya Reviewer: Moon Typesetting: siqili Execution: moly

    Click "Read the original text" to see more content

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.